Humana Surges on CMS 4-Star Reinstatement — MA Margins Get a Direct Lifeline
HUM jumped after its main Medicare Advantage contract regained a 4-star CMS quality rating for 2027, a direct bonus-payment catalyst estimated to meaningfully compress MLR over the next plan year. The star rating system ties substantial revenue bonuses to quality thresholds; Humana's 2025 demotion below 4 stars had triggered a multi-quarter selloff and margin deterioration. The reinstatement is a real event — not a soft reprieve — and the market's relief rally is rational, though the real test is whether Q4 enrollment numbers confirm the thesis. Healthcare's +1.58% sector day was built largely on this plus DVA's buyback-driven recovery, not broad pharma strength.
Read at Seeking Alpha ↗